Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer.
Buonerba C, Pond GR, Sonpavde G, Federico P, Rescigno P, Puglia L, Bosso D, Virtuoso A, Policastro T, Izzo M, Vaccaro L, Ferro M, Aieta M, Perdonà S, Palmieri G, De Placido S, Di Lorenzo G.
Buonerba C, et al. Among authors: de placido s.
Future Oncol. 2013 Jun;9(6):889-97. doi: 10.2217/fon.13.39.
Future Oncol. 2013.
PMID: 23718309